Corporate News     25-Feb-19
Shilpa Medicare receives USFDA approval for Gemcitabine for Injection USP
Shilpa Medicare has received U.S Food and Drug Administration approval for its ANDA, Gemcitabine for Injection USP, 200 mg/vial and 1 g/vial. Gemcitabine for Injection USP is a generic equivalent of reference listed drug (RLD), GEMZAR used in the treatment of ovarian cancer, breast cancer, non-small cell lung cancer & pancreatic cancer as recommended in the label approved by FDA.

According to IQVIA MAT 12/2018, the US market for Gemcitabine for Injection USP, 200 mg/vial and 1 g/vial is approximately US$ 11.7 million.

Previous News
  Shilpa Medicare reports consolidated net profit of Rs 4.58 crore in the December 2023 quarter
 ( Results - Announcements 08-Feb-24   17:40 )
  Shilpa Medicare reports standalone net profit of Rs 2.70 crore in the December 2023 quarter
 ( Results - Announcements 08-Feb-24   17:29 )
  Indices trade with minor losses; bank shares under pressure
 ( Market Commentary - Mid-Session 24-Jul-24   11:32 )
  Shilpa Medicare to conduct AGM
 ( Corporate News - 16-Aug-24   10:54 )
  Shilpa Medicare hits record high on USFDA nod for cancer drug
 ( Hot Pursuit - 27-Aug-24   14:43 )
  Shilpa Medicare reports consolidated net loss of Rs 8.04 crore in the March 2023 quarter
 ( Results - Announcements 25-May-23   16:49 )
  Shilpa Medicare gains on concluding human clinical studies of Adalimumab biosimilar
 ( Hot Pursuit - 22-Aug-22   13:24 )
  Volumes soar at Shilpa Medicare Ltd counter
 ( Hot Pursuit - 24-May-22   14:30 )
  Shilpa Medicare Ltd leads losers in 'A' group
 ( Hot Pursuit - 29-Dec-23   15:00 )
  Shilpa Medicare Karnataka unit clears PMDA inspection
 ( Hot Pursuit - 04-Sep-23   10:04 )
  Shilpa Pharma Lifesciences' API unit in Raichur receives GMP Certification
 ( Corporate News - 23-Jul-24   17:27 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top